# Efficacy and Safety Study of Argatroban to Treat Heparin-Induced Thrombocytopenia

> **NCT00198588** · PHASE3 · COMPLETED · sponsor: **Ministry of Health, Labour and Welfare, Japan** · enrollment: 8 (actual)

## Conditions studied

- Heparin-Induced Thrombocytopenia

## Interventions

- **DRUG:** argatroban

## Key facts

- **NCT ID:** NCT00198588
- **Lead sponsor:** Ministry of Health, Labour and Welfare, Japan
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2006-07
- **Final completion:** 2006-09
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2008-11-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00198588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00198588, "Efficacy and Safety Study of Argatroban to Treat Heparin-Induced Thrombocytopenia". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00198588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*